| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Satsuma Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock, $0.0001 par value | 24.8M | $22.6M | $0.91 | Jun 6, 2023 | Indirect |
| Wave Life Sciences Ltd. | Director, 10%+ Owner | Ordinary Shares | 5.72M | $14.2M | $2.48 | Aug 12, 2024 | Direct |
| Wave Life Sciences Ltd. | Director, 10%+ Owner | Share Option (right to buy) | 32.2K | Aug 12, 2024 | Direct | ||
| Satsuma Pharmaceuticals, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 0 | Jun 8, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| WVE | Wave Life Sciences Ltd. | Aug 12, 2024 | 2 | $0 | 4 | Aug 14, 2024 | Director, 10%+ Owner |
| WVE | Wave Life Sciences Ltd. | Aug 7, 2023 | 1 | $0 | 4 | Aug 9, 2023 | Director, 10%+ Owner |
| STSA | Satsuma Pharmaceuticals, Inc. | Jun 6, 2023 | 4 | $20.1M | 4 | Jun 8, 2023 | Director, 10%+ Owner |
| WVE | Wave Life Sciences Ltd. | Aug 15, 2022 | 1 | $0 | 4 | Aug 17, 2022 | Director, 10%+ Owner |
| STSA | Satsuma Pharmaceuticals, Inc. | Jun 3, 2022 | 1 | $0 | 4/A | Dec 9, 2022 | Director |
| WVE | Wave Life Sciences Ltd. | Aug 16, 2021 | 1 | $0 | 4 | Aug 18, 2021 | Director, 10%+ Owner |